Skip to content

The effect of azithromycin in patients with COPD and chronic productive cough.

The effect of azithromycin in patients with COPD and chronic productive cough. - CACTUS

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31487
Enrollment
84
Registered
2008-09-16
Start date
2008-03-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic bronchitis and emphysema. COPD

Interventions

None listed

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients > 40 years old, in our outpatient clinic with chronic cough and COPD (gold 2-4). 2. Chronic cough is defined as a cough > 12 weeks duration, 2 years in a row. 3. Analysed for bronchiectasis prior to participation.

Exclusion criteria

Exclusion criteria: 1. Use of i.v. or oral corticosteroids and or antibiotics for an exacerbation 3 weeks before inclusion 2. Patients suffering from other relevant lung diseases. 3. Clinically relevant abnormal laboratory values suggesting an unknown disease requiring further clinical evaluation. 4. Liver disease, (ALAT and/or ASAT levels two or more times the upper limit of normal). 5. Pregnancy or lactation. 6. Use of macrolides the last 6 weeks prior to inclusion. 7. Allergy or intolerance to macrolides. 8. Other research medication started 2 months prior to inclusion.

Design outcomes

Primary

MeasureTime frame
LCQ (leicester cough questionnaire)

Secondary

MeasureTime frame
Short form 36, SGRQ. FEV1, VC (spirometry), inflammatory markers sputum, microbiology sputum.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)